11月 2025
- 首頁
- Rutgers Cancer Institute of New Jersey
11月 2025Rutgers Cancer Institute...的市場佔有率分析
rutgers cancer institute in partnership with rwjbarnabas health brings together the top cancer researchers and clinicians throughout new jersey to apply the latest technologies, therapies, & approaches to improve cancer diagnosis, treatment,
Rutgers Cancer Institute of New Jersey(包含公司地區)
查看更多網站流量與參與度資訊- cinj.org
Rutgers Cancer Institute of New Jersey截至 11月 2025 的總收入為 100M - 200M
Rutgers Cancer Institute of New Jersey 熱門網域產生的總收入
Rutgers Cancer Institute of New Jersey 熱門網域 3 年內的總收入
Rutgers Cancer Institute of New Jersey 熱門網域的總收入
Rutgers Cancer Institute of New Jersey的熱門網域總造訪量
了解Rutgers Cancer Institute of New Jersey市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Rutgers Cancer Institute of New Jersey的熱門網域平均造訪時長
分析Rutgers Cancer Institute of New Jersey參與度指標。
過去 3 個月平均造訪時長
子公司細目
Rutgers Cancer Institute of New Jersey的熱門網域平均頁面瀏覽量
了解Rutgers Cancer Institute of New Jersey如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
Rutgers Cancer Institute of New Jersey按網域劃分的熱門競爭對手
11月 2025的熱門類似網站,依相似度排名
標竿分析您的數位績效
辨識高價值機會,追蹤績效並贏得市場。
新聞與訊號來自Rutgers Cancer Institute of New Jersey
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Haystack Oncology, Inc. partnered with The Cancer Institute of New Jersey on Sep 22nd '25.Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, today announced a research collaboration with the Rutgers Cancer Institute to evaluate the use of Haystack MRD(R), a highly sensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) test, to help optimize
9月 22, 2025閱讀更多
新聞The Cancer Institute of New Jersey hires Contessa.Contessa joins Rutgers from Yale University, where he served as professor of therapeutic radiology, co-leader of the Yale Cancer Center Radiobiology and Genome Integrity Research Program, and vice chair for basic science research in therapeutic radiology, among other leadership roles.
8月 6, 2025閱讀更多
新聞The Cancer Institute of New Jersey is developing risk prediction model for early-stage classic hodgkin's lymphoma.RWJBarnabas Health, Rutgers Cancer Institute, tufts medical center, and the university of manchester develop first risk prediction model for early-stage classic hodgkin's lymphoma.
6月 19, 2025閱讀更多
查看所有Rutgers Cancer Institute of New Jersey信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。